KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Change in Receivables (2016 - 2025)

Opko Health (OPK) has disclosed Change in Receivables for 16 consecutive years, with -$6.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables fell 142.19% year-over-year to -$6.7 million, compared with a TTM value of -$30.2 million through Dec 2025, down 13833.18%, and an annual FY2025 reading of -$30.2 million, down 13833.18% over the prior year.
  • Change in Receivables was -$6.7 million for Q4 2025 at Opko Health, down from -$4.4 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $89.2 million in Q2 2023 and bottomed at -$90.6 million in Q3 2023.
  • Average Change in Receivables over 5 years is -$8.4 million, with a median of -$6.3 million recorded in 2024.
  • The sharpest move saw Change in Receivables soared 4518.35% in 2021, then tumbled 1242.2% in 2025.
  • Year by year, Change in Receivables stood at $22.7 million in 2021, then crashed by 93.61% to $1.4 million in 2022, then soared by 267.59% to $5.3 million in 2023, then surged by 198.31% to $15.9 million in 2024, then plummeted by 142.19% to -$6.7 million in 2025.
  • Business Quant data shows Change in Receivables for OPK at -$6.7 million in Q4 2025, -$4.4 million in Q3 2025, and $3.8 million in Q2 2025.